Listen below to each episode of The First Line of Defense: Primary Care Clinicians and Early Detection of Pancreatic Cancer

Click below to play and/or download:

Ep4: A Conversation with Chris Sander on AI and the Prediction of Pancreatic Cancer

This podcast is for non-specialist clinicians who might be the first line of defense for pancreatic cancer diagnoses.

This fourth and final episode is an interview - edited for context and length - with Dr. Chris Sander. Chris Sander is a computational biologist based at the Dana-Farber Cancer Center and Harvard Medical School. Previously he was chair of the Computational Biology Program at the Memorial Sloan–Kettering Cancer Center in New York City. In 2015, he moved his lab to the Dana–Farber Cancer Institute and the Cell Biology Department at Harvard Medical School.

KEEP LISTENING

GO BACK | Ep1 - From Knowledge to Action: Early Detection of Pancreatic Cancer in Primary Care

GO BACK | Ep2 - Genetic Insights: Understanding Pancreatic Cancer Risk in Primary Care

GO BACK | Ep3 - From Data to Diagnosis: Transforming Early Detection of Pancreatic Cancer